As of January 1, 2025, 35 percent of Alzheimer’s disease drugs in clinical trial phase III of development worldwide addressed neurotransmitter receptor mechanisms. This statistic illustrates Alzheimer’s disease drugs in phase III of development worldwide as of early 2025, by type.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Alzheimer's Association. (March 24, 2025). Alzheimer’s disease drugs in clinical trial phase III worldwide as of 2025, by type [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 24, 2026, from /statistics/1173707/alzheimer-disease-therapies-phase-iii-development-type/
Alzheimer's Association. "Alzheimer’s disease drugs in clinical trial phase III worldwide as of 2025, by type." Chart. March 24, 2025. ÌÇÐÄÆÆ½â°æ. Accessed July 24, 2026. /statistics/1173707/alzheimer-disease-therapies-phase-iii-development-type/
Alzheimer's Association. (2025). Alzheimer’s disease drugs in clinical trial phase III worldwide as of 2025, by type. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 24, 2026. /statistics/1173707/alzheimer-disease-therapies-phase-iii-development-type/
Alzheimer's Association. "Alzheimer’s Disease Drugs in Clinical Trial Phase Iii Worldwide as of 2025, by Type." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 24 Mar 2025, /statistics/1173707/alzheimer-disease-therapies-phase-iii-development-type/
Alzheimer's Association, Alzheimer’s disease drugs in clinical trial phase III worldwide as of 2025, by type ÌÇÐÄÆÆ½â°æ, /statistics/1173707/alzheimer-disease-therapies-phase-iii-development-type/ (last visited July 24, 2026)
Alzheimer’s disease drugs in clinical trial phase III worldwide as of 2025, by type [Graph], Alzheimer's Association, March 24, 2025. [Online]. Available: /statistics/1173707/alzheimer-disease-therapies-phase-iii-development-type/